Assessing self-efficacy and well-being in patients with fibrotic interstitial lung disease
Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease - an Observational Study
This study is trying to see how patients with fibrotic interstitial lung disease feel about their quality of life and confidence in managing their health before and after rehabilitation or outpatient care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 80 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Berner Reha Zentrum AG Academic / other |
| Locations | 2 sites (Bern, Heiligenschwendi and 1 other locations) |
| Trial ID | NCT06027333 on ClinicalTrials.gov |
What this trial studies
This observational study invites patients with fibrotic interstitial lung disease (ILD) who are undergoing inpatient rehabilitation or outpatient pulmonary care to participate. Participants will complete questionnaires regarding their quality of life and symptoms at the beginning and end of their rehabilitation or after their second outpatient consultation. The study aims to evaluate changes in self-efficacy and quality of life over time, while also establishing a control cohort for a future feasibility study focused on educational and self-management interventions. Clinical data from routine care and the IIP registry will also be utilized.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older diagnosed with fibrotic interstitial lung disease who are participating in rehabilitation or outpatient care.
Not a fit: Patients with cognitive impairments or those who do not speak German may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of self-efficacy and quality of life in patients with fibrotic ILD, leading to improved patient education and self-management strategies.
How similar studies have performed: While this study is observational and aims to establish a control cohort for future interventions, similar studies have shown promise in improving patient outcomes through self-management and education.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria are: * For Berner Reha Zentrum only: Diagnosis of a FILD as major indication for pulmonary rehabilitation * For Inselspital only: Enrolled in Idiopathic interstitial Pneumonia (IIP) cohort study (Nr. 246/15 / PB_2016-01524) and agreed to further use of data for further research purpose * Age ≥ 18 years * Written informed consent Exclusion criteria are: * Cognitive inability or insufficient knowledge of project language (German) to follow informed consent or study procedures * Sarcoidosis
Where this trial is running
Bern, Heiligenschwendi and 1 other locations
- Berner Reha Zentrum, Rehabilitation & Sports Medicine, Insel Group, University Hospital Berne — Bern, Heiligenschwendi, Switzerland (Recruiting)
- Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern — Bern, Switzerland (Recruiting)
Study contacts
- Study coordinator: Thimo Marcin, PhD
- Email: t.marcin@rehabern.ch
- Phone: +41 33 244 30 48
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.